China Releases First Guideline On Clinical Trial Ethical Reviews In Effort To Improve Standards
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA released Nov. 2 its first guideline on the Ethical Review of Drug Clinical Trials to clarify the responsibility of ethics committees and to provide clear guidance on the ethical review process in an effort to better protect patients participating in trials